Search Resources (English): Sexuality

Result 41 of 41


FDA hearing on flibanserin

Read the New View Campaign’s comments on US FDA hearings for approval of Flibanserin:

“On June 18, 2010, the FDA Reproductive Health Advisory Committee convenes for the second time to consider a drug for "female sexual dysfunction" (the first drug, Intrinsa, failed in 2004). The New View Campaign opposes the approval of flibanserin, and is preparing factsheets and petitions, has spoken to endless media, and will be participating in the hearing as part of the section on public speakers. In combination with the materials we prepared in 2004 for the Intrinsa hearing, these resources offer a rich analysis of the medicalization of sexuality.”

 (See Details)
Published: 2010